Journal Title
Cancer Genomics & Proteomics

CANCER GENOM PROTEOM

ISSN / eISSN
1109-6535 / 1790-6245
Aims and Scope
Cancer Genomics & Proteomics (CGP) is an international peer-reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising. The first issue of CGP circulated in January 2004.
Cancer Genomics & Proteomics is a journal of the International Institute of Anticancer Research. From January 2013 CGP is converted to an online-only open access journal.

Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.
Subject Area

GENETICS & HEREDITY

ONCOLOGY

CiteScore
5.00 View Trend
CiteScore Ranking
Category Quartile Rank
Biochemistry, Genetics and Molecular Biology - Genetics Q2 #170/347
Biochemistry, Genetics and Molecular Biology - Biochemistry Q3 #247/438
Biochemistry, Genetics and Molecular Biology - Cancer Research Q3 #135/230
Biochemistry, Genetics and Molecular Biology - Molecular Biology Q3 #251/410
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
GENETICS & HEREDITY Q2
ONCOLOGY Q3
H-index
32
Country/Area of Publication
GREECE
Publisher
International Institute of Anticancer Research
Annual Article Volume
66
Open Access
NO
Contact
EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS, GREECE, 19014

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More